Calies Menard-Katcher

Dr. Calies Menard-Katcher


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
CMCalies Menard-Katcher
Calies Menard-Katcher
ABAlain J Benitez
Alain J Benitez
ZPZhaoxing Pan
Zhaoxing Pan
FAFaria N Ahmed
Faria N Ahmed
BWBenjamin J Wilkins
Benjamin J Wilkins
AMAmanda B. Muir
Amanda B. Muir
Ility of the esophagus in adult patients with EoE. As the impact of inflammation on the developing esophagus is unknown, we investigated esophageal distensibility in a pediatric cohort to determine the effect of age, ongoing inflammation, and fibrotic features on distensibility. Methods: We conducted a prospective observational study at two tertiary pediatric institutions. Subjects underwent FLIP evaluation during endoscopy to determine distensibility of the esophagus. During stepwise distension, simultaneous intrabag pressure and 16 channels of cross-sectional areas were measured. The minimal diameter at maximal esophageal distention at an intrabag pressure of 40 mm Hg was identified. Distensibility was compared between EoE and non-EoE subjects and between clinical variables within the EoE cohort. Potential confounding variables were identified. Results: Forty-four non-EoE and 88 EoE subjects aged 3–18 years were evaluated. Age positively correlated with esophageal distensibility in the non-EoE cohort, but this trend was not observed in the EoE population. Subjects with EoE had reduced distensibility even after adjusting for age. Active inflammation (eosinophils >15 eos/high-power field), histological lamina propria fibrosis, and various features of a fibrotic phenotype (stricture, food impaction, circumferential rings on endoscopy) were associated with decreased distensibility within the EoE cohort. FLIP was safe, feasible, and well tolerated. Conclusions: These findings suggest that remodeling occurs in the pediatric EoE population, warranting early diagnosis and initiation of therapy prior to the onset of disease complications....

1 November 2015 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
CMCalies Menard-Katcher
Calies Menard-Katcher
MSMathew P. Swerdlow
Mathew P. Swerdlow
PMPooja Mehta
Pooja Mehta
GFGlenn T. Furuta
Glenn T. Furuta
LFLaura Z. Fenton
Laura Z. Fenton

26 November 2019 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
T(the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)
the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)
RPRobert D. Pesek
Robert D. Pesek
CRCraig C. Reed
Craig C. Reed
MCMargaret Helen Collins
Margaret Helen Collins
AMAmanda B. Muir
Amanda B. Muir
EDEvan S. Dellon
Evan S. Dellon

8 April 2022 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
AMAmanda B. Muir
Amanda B. Muir
SASteven J. Ackerman
Steven J. Ackerman
ZPZhaoxing Pan
Zhaoxing Pan
ABAlain Benitez
Alain Benitez
CBCassandra Burger
Cassandra Burger
CMCalies Menard-Katcher
Calies Menard-Katcher

1 May 2017 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
CMCalies Menard-Katcher
Calies Menard-Katcher
GFGlenn T. Furuta
Glenn T. Furuta
RKRobert E. Kramer
Robert E. Kramer

17 February 2021 in Cells
Verified
Journal Article
Open access
PDF file
JMJoanne Masterson
Joanne Masterson
CMCalies Menard-Katcher
Calies Menard-Katcher
LLLeigha D. Larsen
Leigha D. Larsen
GFGlenn Furuta
Glenn Furuta
LSLisa Spencer
Lisa Spencer
Eosinophils are implicated in the pathophysiology of a spectrum of eosinophil-associated diseases, including gastrointestinal eosinophilic diseases (EGIDs). Biologics that target the IL-5 pathway and are intended to ablate eosinophils have proved beneficial in severe eosinophilic asthma and may offer promise in treating some endotypes of EGIDs. However, destructive effector functions of eosinophils are only one side of the coin; eosinophils also play important roles in immune and tissue homeostasis. A growing body of data suggest tissue eosinophils represent a plastic and heterogeneous population of functional sub-phenotypes, shaped by environmental (systemic and local) pressures, which may differentially impact disease outcomes. This may be particularly relevant to the GI tract, wherein the highest density of eosinophils reside in the steady state, resident immune cells are exposed to an especially broad range of external and internal environmental pressures, and greater eosinophil longevity may uniquely enrich for co-expression of eosinophil sub-phenotypes. Here we review the growing evidence for functional sub-phenotypes of intestinal tissue eosinophils, with emphasis on the multifactorial pressures that shape and diversify eosinophil identity and potential targets to inform next-generation eosinophil-targeting strategies designed to restrain inflammatory eosinophil functions while sustaining homeostatic roles.